The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.

To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.

For additional information please review our Privacy Policy.

Effects of complementary and alternative medicine use on hopelessness in ovarian cancer patients.

Print

Sub-category:
Quality-of-Life Management

Category:
Patient Care

Meeting:
2008 ASCO Annual Meeting

Session Type and Session Title:
General Poster Session, Patient and Survivor Care

Abstract No:
9598

Citation:
J Clin Oncol 26: 2008 (May 20 suppl; abstr 9598)

Author(s):
A. H. Gross, J. Cromwell, A. B. Kornblith, H. Lee, H. Li, L. Pereira, R. T. Penson, U. A. Matulonis

Abstract:

Background: Hopelessness is a significant factor affecting the quality of life (QOL) of cancer patients (pts). Despite the millions of dollars spent annually on Complementary and Alternative Medicine use (CAM) there is little research demonstrating any beneficial effect of CAM on QOL and hope despite the fact that these are reasons patients cite for using CAM. Methods: A secondary dataset (n=130 pts) was concatenated from subsets of 2 QOL studies of ovarian cancer pts. A recursive path model was estimated to quantify the hypothesized direct and indirect effects of recurrence and age (>55 yrs) on spirituality (FACT Spirituality Scale), # of CAM use (special diet, psychotherapy, movement, physical therapies, mind/body, spiritual practices, vitamins, herbs) and on feelings of hopelessness (Beck's Hopelessness Scale). Age and recurrence were also hypothesized to affect hopelessness indirectly through spirituality, which in turn should raise CAM use and reduce hopelessness. Results: Pt median age was 55, range 34-87 years. 73 had recurrent disease (RD). 57 were survivors > 3 years from diagnosis without RD. 97% of all pts reported use of CAM however CAM had only a minimal positive, insignificant effect on hopelessness controlling for other factors. RD directly increased hopelessness (path coefficient [PC] 0.32, p<0.001) which was significantly offset due to heightened spirituality by some RD pts (PC 0.24, p<0.01) that reduced hopelessness (PC -0.56, p<0.001). Older pts were likely to use fewer CAMs (PC -0.26, p<0.01) but were not more spiritual or more hopeful, controlling for RD. A continuous age variable was positively correlated with RD implying another path of age to hopelessness. Conclusions: A significant causal relationship between CAM use and hopelessness was not established. Feelings of hopelessness, natural in pts with RD, were significantly offset through their spirituality. Increasing spirituality, especially among RD pts may significantly improve feelings of hopefulness. Future research should explore direct effects of specific CAM therapies, excluding spiritual practices, on QOL and hope, the interactive relationship between spirituality and hopefulness and continuous effects of age on both recurrence and hope.


Abstract Disclosures

Abstracts that were granted an exception in accordance with ASCO's Conflict of Interest Policy and are designated with a caret symbol (^) here and in the print version.


  Associated Presentation(s):

    

1. Effects of complementary and alternative medicine use on hopelessness in ovarian cancer patients.

Meeting: 2008 ASCO Annual Meeting
Presenter: Anne H Gross, MS, RN
Session: Patient and Survivor Care (General Poster Session)


  Other Abstracts in this Sub-Category:

    

1. A patient-level meta-analytic investigation of the prognostic significance of baseline quality of life (QOL) for overall survival (OS) among 3,704 patients participating in 24 North Central Cancer Treatment Group (NCCTG) and Mayo Clinic Cancer Center (MC) oncology clinical trials.

Meeting: 2008 ASCO Annual Meeting   Abstract No: 9515   First Author: A. D. TAN
Category: Patient Care - Quality-of-Life Management

    

2. An examination into quality of life as a prognostic survival indicator. Results of a meta-analysis of over 10,000 patients covering 30 EORTC clinical trials.

Meeting: 2008 ASCO Annual Meeting   Abstract No: 9516   First Author: C. Quinten
Category: Patient Care - Quality-of-Life Management

    

3. Electronic self-report assessment for cancer (ESRA-C): Results of a randomized clinical trial.

Meeting: 2008 ASCO Annual Meeting   Abstract No: 9519   First Author: D. L. Berry
Category: Patient Care - Quality-of-Life Management

    

More...


  Abstracts by A. H. Gross :

    

1. Effects of complementary and alternative medicine use on hopelessness in ovarian cancer patients.

Meeting: 2008 ASCO Annual Meeting   Abstract No: 9598   First Author: A. H. Gross
Category: Patient Care - Quality-of-Life Management

    

2. Rapid inpatient and outpatient desensitization for carboplatin or paclitaxel hypersensitivity: a protocol effective in patients with gynecologic malignancies

Meeting: 2005 ASCO Annual Meeting   Abstract No: 5090   First Author: C. Lee
Category: Gynecologic Cancer

    

More...


  Presentations by A. H. Gross :

    

1. Effects of complementary and alternative medicine use on hopelessness in ovarian cancer patients.

Meeting: 2008 ASCO Annual Meeting
Presenter: Anne H Gross, MS, RN
Session: Patient and Survivor Care (General Poster Session)

    

More...


  Educational Book Manuscripts by A. H. Gross :

    

No items found.




 
2318 Mill Road, Suite 800, Alexandria, VA 22314   |   phone: (571) 483-1300
© 2005-2009 American Society of Clinical Oncology (ASCO).  All rights reserved worldwide.